China National Accord Medicines Corp Ltd (200028) — Cash Flow Reinvestment Rate
China National Accord Medicines Corp Ltd (200028) has a Cash Flow Reinvestment Rate of 0.05x as of June 2025, reinvesting HK$95.44 Million (capex HK$50.09 Million plus investments HK$45.35 Million) from operating cash flow of HK$1.83 Billion. Check China National Accord Medicines Corp Ltd (200028) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China National Accord Medicines Corp Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for China National Accord Medicines Corp Ltd across 27 annual periods. Explore long-term investment intensity of China National Accord Medicines Corp Ltd to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for China National Accord Medicines Corp Ltd (1998–2025)
Year-by-year capital reinvestment analysis for China National Accord Medicines Corp Ltd. For live market cap and broader valuation context, see 200028 market cap.
| Year | Reinvestment Rate | Total Reinvested (HKD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | HK$337.47 Million | HK$1.64 Billion | HK$217.35 Million | ▲ +41.3% |
| 2024 | 0.15x | HK$476.87 Million | HK$3.27 Billion | HK$282.70 Million | ▼ -6.4% |
| 2023 | 0.16x | HK$457.64 Million | HK$2.94 Billion | HK$322.21 Million | ▼ -40.0% |
| 2022 | 0.26x | HK$665.01 Million | HK$2.56 Billion | HK$322.19 Million | ▼ -16.4% |
| 2021 | 0.31x | HK$514.46 Million | HK$1.66 Billion | HK$370.43 Million | ▲ +43.8% |
| 2020 | 0.22x | HK$324.92 Million | HK$1.50 Billion | HK$293.83 Million | ▲ +43.6% |
| 2019 | 0.15x | HK$301.17 Million | HK$2.00 Billion | HK$245.17 Million | ▼ -47.6% |
| 2018 | 0.29x | HK$380.06 Million | HK$1.32 Billion | HK$255.48 Million | ▲ +70.1% |
| 2017 | 0.17x | HK$217.09 Million | HK$1.29 Billion | HK$204.35 Million | ▼ -9.6% |
| 2016 | 0.19x | HK$275.02 Million | HK$1.47 Billion | HK$265.89 Million | ▼ -13.7% |
| 2015 | 0.22x | HK$226.73 Million | HK$1.05 Billion | HK$190.36 Million | ▼ -33.1% |
| 2013 | 0.32x | HK$150.50 Million | HK$465.03 Million | HK$150.50 Million | ▼ -45.8% |
| 2012 | 0.60x | HK$193.57 Million | HK$323.96 Million | HK$193.57 Million | ▼ -31.7% |
| 2011 | 0.88x | HK$198.97 Million | HK$227.32 Million | HK$198.97 Million | ▲ +110.6% |
| 2010 | 0.42x | HK$177.99 Million | HK$428.16 Million | HK$177.99 Million | ▲ +9.4% |
| 2009 | 0.38x | HK$102.94 Million | HK$270.85 Million | HK$102.94 Million | ▲ +10.3% |
| 2008 | 0.34x | HK$84.98 Million | HK$246.58 Million | HK$84.98 Million | ▼ -57.7% |
| 2007 | 0.81x | HK$71.41 Million | HK$87.70 Million | HK$71.41 Million | ▲ +25.2% |
| 2006 | 0.65x | HK$118.22 Million | HK$181.73 Million | HK$118.22 Million | ▲ +90.5% |
| 2005 | 0.34x | HK$50.62 Million | HK$148.28 Million | HK$50.62 Million | ▲ +213.6% |
| 2004 | 0.11x | HK$14.18 Million | HK$130.30 Million | HK$14.18 Million | ▼ -82.1% |
| 2003 | 0.61x | HK$49.36 Million | HK$81.22 Million | HK$49.36 Million | ▼ -35.0% |
| 2002 | 0.94x | HK$26.90 Million | HK$28.76 Million | HK$26.90 Million | ▲ +85.3% |
| 2001 | 0.50x | HK$35.91 Million | HK$71.16 Million | HK$35.91 Million | ▼ -79.5% |
| 2000 | 2.47x | HK$21.01 Million | HK$8.52 Million | HK$21.01 Million | ▲ +104.6% |
| 1999 | 1.21x | HK$27.54 Million | HK$22.84 Million | HK$27.54 Million | ▼ -39.5% |
| 1998 | 1.99x | HK$10.38 Million | HK$5.21 Million | HK$10.38 Million | — |